Posts

Showing posts from September, 2017

Alcohol advertising linked to adolescent drinking

These findings support the demand for legal restrictions of the amount of alcohol marketing in the European Union, where the Audio Visual Media Services Directive (AVMSD) is the only EU regulation currently in place. The AVMSD regulates the content of alcohol marketing in audiovisual media but does not restrict the amount of alcohol marketing on TV or elsewhere. The study included more than 9,000 adolescents in Germany, Italy, Netherlands, and Poland. The average age was 14 years. The students reported their drinking frequency and binge drinking as well as their exposure to a wide range of alcohol marketing, including television ads; online marketing; sponsorship of sports, music events, or festivals; ownership of alcohol branded promotional items; receipt of free samples; and exposure to price offers. The data showed that exposure to alcohol marketing o f all kinds was positively associated with adolescents' alcohol use over time. This link was found in four countries of v

Preventing dependency when patients first receive opioids: Say no to refills

A substantial increase in opioid prescriptions over the past two decades in the US has gone hand-in-hand with a significant rise in overdoses and addiction treatment. These trends have prompted calls for the more selective use of opioids for medical reasons. Deyo's team wanted to shed light on how much and for how long opioids can be prescribed for the first time to so-called opioid-naïve patients without their inadvertently becoming long-term users. They focused their attention on Oregon, the US state with the highest rate of non-medical opioid users in a 2012 survey. One year's data was obtained from Oregon's prescription monitoring program about outpatient prescriptions filled for controlled substances, including opioids, at all non-state or non-federal retail pharmacies. Data from Oregon vital records and a statewide hospital discharge registry were also included. Deyo's team began with data from 3.6 million opioid prescriptions filled for 874,765 patients. Of t

Prescription drug abuse in Europe is a bigger problem than previously thought

Nonmedical prescription drug use is typically defined as either the self-treatment of a medical condition using prescription medication that was not prescribed to the user, or as the use of prescription medication to achieve euphoric states. A research team led by scientists at RTI International in the US investigated nonmedical prescription drug use as it is among the leading public health issues in the US and previous research has suggested that it is more widespread there than in the EU, where prevalence and user characteristics remain largely unknown. Dr Scott Novak, lead author of the study, said: "This is the first comparative study of prescription drug abuse in the European Union. Previously it was thought that the prescription drug epidemic was limited to the United States, but this study shows that the epidemic extends well beyond the US." Examining three different classes of subscription drug -- opioids, sedatives and stimulants -- the researchers found tha

Drink-seeking rats provide sobering look into genetics of alcoholism

By comparing the genomes of rats that drank compulsively with those that abstained, Purdue and Indiana University researchers identified 930 genes associated with alcoholism, indicating that it is a highly complex trait - on par with human height - influenced by many genes and the environment. The study confirmed genes previous ly identified as being l inked to alcoholism and uncovered new genes and neurological pathways, some of which could be promising targets for treatment. But the sheer number of genes that contribute to the trait suggests pharmaceutical treatments for alcoholism could be difficult to develop, said William Muir, professor of genetics. "It's not one gene, one problem," he said. "This trait is controlled by vast numbers of genes and networks. This probably dashes water on the idea of treating alcoholism with a single pill." One of the best predictors of alcoholism in humans is the drinking behavior of their families. But to what extent

College students who misuse stimulants more likely to have ADHD, substance-use disorder

"Our data suggest that college students who misuse prescription stimulant medications are more likely to exhibit clinically relevant psychiatric dysfunction," says Timothy Wilens, MD, chief of Child and Adolescent Psychiatry at MassGeneral Hospital for Children (MGHfC) and co-director of the MGH Center for Addiction Medicine, corresponding author of the report. "In addition to higher levels of ADHD, conduct disorder, and alcohol or drug use disorders, the majority of those misusing stimulants met or approached criteria for stimulant-use disorder." Stimulant drugs are widely prescribed to treat ADHD, which is believed to affect up to 8 percent of U.S. college students, and several studies have documented frequent nonmedical use -- either without a prescription or taking higher-than-prescribed doses -- particularly among college students. One recent study found that almost two thirds of college students had been offered stimulants for nonmedical use and 31 percen

Study finds racial disparity in emergency department opioid prescriptions

The team's results show that black patients who visit emergency rooms with back and abdominal pain are significantly less likely to receive opioid prescriptions than white patients with the same pain level. These conditions are referred to as 'non-definitive conditions' as they do not have a clear clinical presentation, and are often difficult to diagnose. It is important to note that no difference was found for visits pertaining to fractures, kidney stones or toothaches . Given the prescription opioid epidemic throughout the country, physicians and hospitals are under increased pressure to be vigilant when prescribing such medications. As such, doctors may be relying on subjective cues such as race when prescribing opioids for pain-related conditions. The researchers conducted their experiment using the National Hospital Ambulatory Medical Care Survey (NHAMCS). Examining medications prescribed and administered in emergency departments over a five-year period from 2007

Highly curative hep C treatment safe, effective for drug users

Up to 170 million people worldwide have hepatiti s C virus (HCV) infection and injection drug use is a major risk factor. While the once-daily dosing, low side-effects profile, and shortened treatment duration of interferon-free direct-acting antivirals are ideal for injection drug users, most trials of these therapies for HCV have excluded persons with recent injection drug use. The CO-STAR (Hepatitis C Patients on Opioid Substitution Therapy Antiviral Response) trial sought to evaluate the efficacy and safety of elbasvir-grazoprevir for injection drug users. Researchers assigned 301 treatment-naive patients with chronic HCV genotype 1, 4, or 6 infection who were at least 80 percent adherent to visits for opioid-agonist therapy to immediate treatment with elbasvir-grazoprevir for 12 weeks, or deferred treatment with placebo for 12 weeks, then open-label elbasvir-grazoprevir for 12 weeks. They found that 91.5 percent of the patients in the immediate treatment group achieved susta

Molecule in brain may drive cocaine addiction, scientists show

The research, published recently online ahead of print in the journal  Biological Psychiatry , shows that blocking hypocretin may reduce compulsive drug-seeking behavior in rat models of cocaine addiction. "Cocaine addiction is a disorder that affects millions of people worldwide," said Marisa Roberto, professor in TSRI's Committee on the Neurobiology of Addictive Disorders (CNAD) and co-author of the study with Brooke Schmeichel, a former TSRI researcher now at NIDA, George Koob, the CNAD chairman currently on a leave of absence to direct the NIAAA, and Melissa Herman, a senior research associate at TSRI. "Understanding the mechanisms underlying cocaine addiction is important for identifying potential new targets for therapeutic use." "The results of this study would suggest that the hypocretin system could be considered a pharmacological target, with the hopes that such a medication could be used in combination with cognitive b ehavioral therapies

New study evaluates link between young women's beliefs on alcohol use and sexual risk-taking

New research from the University of Cincinnati College of Medicine shows that just over two-thirds (66.9 percent) of college-aged women engaged in unprotected sex during their last sexual encounter involving alcohol. The study, published online in the  Journal of Behavioral Medicine , set out to understand how one's beliefs about alcohol and sex affect condom use during sexual encounters involving alcohol. Based on participants surveyed, sex without a condom was significantly and positively related to both one's motivation for sexual activity to satisfy personal physical needs and stronger beliefs that alcohol promotes sexual risk-taking. "Understanding the factors that may underlie the association between alcohol and condomless sex among young women is of considerable public health importance," says Jennifer Brown, PhD, lead author and associate professor in the Department of Psychiatry and Behavioral Neuroscience at the UC College of Medicine. "Particula

New, improved guidelines for diagnosing fetal alcohol spectrum disorder

The proposed guidelines include a new definition of documented prenatal alcohol exposure, guides to evaluating facial and physical deformities characteristic of FASD, and updated information about the cognitive and/or behavioral impairments seen in different FASD subtypes. "These new guidelines will be a valuable resource for clinicians to accurately diagnose infants and children who were affected by alcohol exposure before birth," said NIAAA Director George F. Koob, PhD. "They represent the most data-driven diagnostic criteria for fetal alcohol syndrome and fetal alcohol spectrum disorder produced to date." The updated guidelines were developed and accepted by the Collaboration on FASD Prevalence (CoFASP), which studies the prevalence of FASD among U.S. school children, and NIAAA's Collaborative Initiative on Fetal Alcohol Spectrum Disorders (CIFASD), which investigates data-driven methods for diagnosing FASD. The paper currently appears online in  Pedi